Community post

Adaptive Phage Therapeutics has deployed their PhageBank™ in Texas to treat COVID-19 patients suffering from life-threatening carbapenem resistant Acinetobacter baumannii (CRAB). Eight of these patients have so far received PhageBank™ therapy, with more anticipated.